362 related articles for article (PubMed ID: 27265353)
1. Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial.
Berkley JA; Ngari M; Thitiri J; Mwalekwa L; Timbwa M; Hamid F; Ali R; Shangala J; Mturi N; Jones KD; Alphan H; Mutai B; Bandika V; Hemed T; Awuondo K; Morpeth S; Kariuki S; Fegan G
Lancet Glob Health; 2016 Jul; 4(7):e464-73. PubMed ID: 27265353
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
[TBL] [Abstract][Full Text] [Related]
3. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
[TBL] [Abstract][Full Text] [Related]
6. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Chintu C; Bhat GJ; Walker AS; Mulenga V; Sinyinza F; Lishimpi K; Farrelly L; Kaganson N; Zumla A; Gillespie SH; Nunn AJ; Gibb DM;
Lancet; 2004 Nov 20-26; 364(9448):1865-71. PubMed ID: 15555666
[TBL] [Abstract][Full Text] [Related]
7. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
8. Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial.
Maitland K; Olupot-Olupot P; Kiguli S; Chagaluka G; Alaroker F; Opoka RO; Mpoya A; Walsh K; Engoru C; Nteziyaremye J; Mallewa M; Kennedy N; Nakuya M; Namayanja C; Kayaga J; Nabawanuka E; Sennyondo T; Aromut D; Kumwenda F; Musika CW; Thomason MJ; Bates I; von Hensbroek MB; Evans JA; Uyoga S; Williams TN; Frost G; George EC; Gibb DM; Walker AS;
Lancet Glob Health; 2019 Oct; 7(10):e1435-e1447. PubMed ID: 31537373
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
Otieno L; Oneko M; Otieno W; Abuodha J; Owino E; Odero C; Mendoza YG; Andagalu B; Awino N; Ivinson K; Heerwegh D; Otsyula N; Oziemkowska M; Usuf EA; Otieno A; Otieno K; Leboulleux D; Leach A; Oyieko J; Slutsker L; Lievens M; Cowden J; Lapierre D; Kariuki S; Ogutu B; Vekemans J; Hamel MJ
Lancet Infect Dis; 2016 Oct; 16(10):1134-1144. PubMed ID: 27394191
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Monahan I; Karunanithi K; Dignum H; Belsham E; Neilson J; Harrison B; Lokare A; Campbell G; Hamblin M; Hawkey P; Whittaker AC; Low E; Dunn JA;
Lancet Oncol; 2019 Dec; 20(12):1760-1772. PubMed ID: 31668592
[TBL] [Abstract][Full Text] [Related]
11. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
Hammond M; Clark AB; Cahn AP; Chilvers ER; Fraser WD; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett D; Whyte M; Wilson A
Trials; 2018 Feb; 19(1):89. PubMed ID: 29402332
[TBL] [Abstract][Full Text] [Related]
12. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
[TBL] [Abstract][Full Text] [Related]
13. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
[TBL] [Abstract][Full Text] [Related]
14. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
Anglaret X; Chêne G; Attia A; Toure S; Lafont S; Combe P; Manlan K; N'Dri-Yoman T; Salamon R
Lancet; 1999 May; 353(9163):1463-8. PubMed ID: 10232311
[TBL] [Abstract][Full Text] [Related]
15. Azithromycin for the prevention of rehospitalisation and death among Kenyan children being discharged from hospital: a double-blind, placebo-controlled, randomised controlled trial.
Pavlinac PB; Singa BO; Tickell KD; Brander RL; McGrath CJ; Amondi M; Otieno J; Akinyi E; Rwigi D; Carreon JD; Tornberg-Belanger SN; Nduati R; Babigumira JB; Meshak L; Bogonko G; Kariuki S; Richardson BA; John-Stewart GC; Walson JL
Lancet Glob Health; 2021 Nov; 9(11):e1569-e1578. PubMed ID: 34559992
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
[TBL] [Abstract][Full Text] [Related]
18. Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial.
Njuguna IN; Cranmer LM; Otieno VO; Mugo C; Okinyi HM; Benki-Nugent S; Richardson B; Stern J; Maleche-Obimbo E; Wamalwa DC; John-Stewart GC
Lancet HIV; 2018 Jan; 5(1):e12-e22. PubMed ID: 29150377
[TBL] [Abstract][Full Text] [Related]
19. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial.
Bowen AC; Tong SY; Andrews RM; O'Meara IM; McDonald MI; Chatfield MD; Currie BJ; Carapetis JR
Lancet; 2014 Dec; 384(9960):2132-40. PubMed ID: 25172376
[TBL] [Abstract][Full Text] [Related]
20. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
